Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Our report is an authoritative Owner’s Manual on the company.
- A vital piece in the investor’s toolbox, our report allows you to uncover the essence of the business
- We pinpoint strengths and weaknesses; discuss strategy
- Our aim is to make deep knowledge about the company readily available, saving investors time and enabling dialogue

We offer our research as a service for Japanese corporates.
- Our in-depth reports allow them to better inform investors by presenting an unbiased third-party view of business fundamentals
- Our reports do not offer investment opinions and are free for all investors

We start our coverage with a substantial core report.
- We continuously update this report to reflect earnings, news flow, and any material developments
- We thoroughly interview management on a quarterly basis

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Organo reported FY03/26 orders of JPY168.0bn, revenue of JPY177.7bn, and net income of JPY28.4bn.</li><li>For FY03/27, Organo forecasts orders of JPY230.0bn, revenue of JPY200.0bn, and net income of JPY30.0bn.</li><li>Organo's medium-term plan targets FY03/31 revenue of JPY260.0bn and an OPM of 18–20%.</li></ul>

Organo reported FY03/26 orders of JPY168.0bn, revenue of JPY177.7bn, and net income of JPY28.4bn.For FY03/27, Organo forecasts orders of JPY230.0bn, revenue of JPY200.0bn, and net income of JPY30.0bn.Organo's medium-term plan targets FY03/31 revenue of JPY260.0bn and an OPM of 18–20%.

Organo Corp (6368 JP): Full-year FY03/26 flash update